Delivery Order SPE2DB24D2100-SPE2DB25FBARU

Award Date 10/29/24
Potential Completion Date 11/20/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, under an Indefinite Delivery Contract (IDC) valued at $999,999,999. The delivery order, valued at $1,129.80, is for the procurement of Pfizer COVID-19 vaccines for the 2024-2025 time period, with an ultimate completion date of February 18, 2025. The contract is designated as Firm Fixed Price and does not have a set-aside requirement. This delivery order...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Pfizer COVID-19 vaccines and related medical products. The $11,357.70 firm fixed-price contract has an ultimate completion date of October 10, 2024. The award is likely part of a larger indefinite delivery contract the company holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a...
This is a $1,622.03 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order is for the procurement of Pfizer COVID-19 vaccines, with a period of performance from January 2024 to January 2025. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract...
This federal contract award is a delivery order (SPE2DB25FE7XC) issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,135.77 contract is for the delivery of PFIZER COVID 2024-25 (6M-4Y) EUA 0.9ML vaccine doses, with an ultimate completion date of November 18, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,129.80, is for the procurement of Pfizer COVID-19 vaccine doses to support vaccine requirements from 2024 to 2025, with a potential treatment window of 6 months to 4 years. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a...
This federal contract award, valued at $1,081.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Pfizer COVID-19 vaccines in 0.9 mL doses, with an ultimate completion date of March 4, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,525.97 firm-fixed-price contract is for the supply of the Pfizer COVID-19 vaccine under the Emergency Use Authorization (EUA) for the 2023-2024 period, with an ultimate completion date of April 22, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to...
This is a $1,129.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 0.9 ML Pfizer COVID-19 vaccines from 2024-2025. The contract has an ultimate completion date of February 25, 2025 and was awarded on February 3, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order award by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 0.9 ml COVID-19 vaccine doses for the 2023-2024 period. The delivery order, valued at $1,069.25, is structured as a firm fixed price contract. The award is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025,...
This federal contract award is for the delivery of Pfizer COVID-19 vaccine doses to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,642.75 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on October 22, 2024. The contract has an ultimate completion date of November 13, 2024 and does not have a set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBARU
    Delivery Order

This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The order, valued at $1,135.77, is for the procurement of Pfizer COVID-19 vaccines with a 0.9mL dosage for the 2024-2025 period, under a Firm Fixed Price contract. The award has an ultimate completion date of November 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA, which serves as a vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 1/28/25, 12:26 PM